HEADER PROTEINASE INHIBITOR 08-SEP-88 7API TITLE THE S VARIANT OF HUMAN ALPHA1-ANTITRYPSIN, STRUCTURE AND IMPLICATIONS TITLE 2 FOR FUNCTION AND METABOLISM CAVEAT 7API MAN C 3 HAS WRONG CHIRALITY AT ATOM C1 NAG E 1 HAS WRONG CAVEAT 2 7API CHIRALITY AT ATOM C1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALPHA 1-ANTITRYPSIN; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: ALPHA 1-ANTITRYPSIN; COMPND 7 CHAIN: B; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 MOL_ID: 2; SOURCE 6 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 7 ORGANISM_COMMON: HUMAN; SOURCE 8 ORGANISM_TAXID: 9606 KEYWDS PROTEINASE INHIBITOR EXPDTA X-RAY DIFFRACTION AUTHOR H.LOEBERMANN,R.TOKUOKA,J.DEISENHOFER,R.HUBER REVDAT 7 10-JAN-24 7API 1 REMARK HETSYN LINK REVDAT 6 29-JUL-20 7API 1 CAVEAT COMPND REMARK HETNAM REVDAT 6 2 1 SSBOND LINK SITE ATOM REVDAT 5 13-JUL-11 7API 1 VERSN REVDAT 4 25-AUG-09 7API 1 SOURCE REVDAT 3 24-FEB-09 7API 1 VERSN REVDAT 2 01-APR-03 7API 1 JRNL REVDAT 1 15-OCT-90 7API 0 SPRSDE 15-OCT-90 7API 5API JRNL AUTH R.ENGH,H.LOBERMANN,M.SCHNEIDER,G.WIEGAND,R.HUBER,C.B.LAURELL JRNL TITL THE S VARIANT OF HUMAN ALPHA 1-ANTITRYPSIN, STRUCTURE AND JRNL TITL 2 IMPLICATIONS FOR FUNCTION AND METABOLISM. JRNL REF PROTEIN ENG. V. 2 407 1989 JRNL REFN ISSN 0269-2139 JRNL PMID 2785270 JRNL DOI 10.1093/PROTEIN/2.6.407 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH H.LOEBERMANN,R.TOKUOKA,J.DEISENHOFER,R.HUBER REMARK 1 TITL HUMAN ALPHA1-PROTEINASE INHIBITOR. CRYSTAL STRUCTURE REMARK 1 TITL 2 ANALYSIS OF TWO CRYSTAL MODIFICATIONS, MOLECULAR MODEL AND REMARK 1 TITL 3 PRELIMINARY ANALYSIS OF THE IMPLICATIONS FOR FUNCTION REMARK 1 REF J.MOL.BIOL. V. 177 531 1984 REMARK 1 REFN ISSN 0022-2836 REMARK 1 REFERENCE 2 REMARK 1 AUTH H.LOEBERMANN,F.LOTTSPEICH,W.BODE,R.HUBER REMARK 1 TITL INTERACTION OF HUMAN ALPHA1-PROTEINASE INHIBITOR WITH REMARK 1 TITL 2 CHYMOTRYPSINOGENA AND CRYSTALLIZATION OF A PROTEOLYTICALLY REMARK 1 TITL 3 MODIFIED ALPHA1-PROTEINASE INHIBITOR REMARK 1 REF HOPPE-SEYLER'S V. 363 1377 1982 REMARK 1 REF 2 Z.PHYSIOL.CHEM. REMARK 1 REFN ISSN 0018-4888 REMARK 1 REFERENCE 3 REMARK 1 AUTH J.CARLSON,J.STENFLO REMARK 1 TITL THE BIOSYNTHESIS OF RAT ALPHA1-ANTITRYPSIN REMARK 1 REF J.BIOL.CHEM. V. 257 12987 1982 REMARK 1 REFN ISSN 0021-9258 REMARK 1 REFERENCE 4 REMARK 1 AUTH R.W.CARRELL,J.-O.JEPPSSON,L.VAUGHAN,S.O.BRENNAN,M.C.OWEN, REMARK 1 AUTH 2 D.R.BOSWELL REMARK 1 TITL HUMAN ALPHA1-ANTITRYPSIN. CARBOHYDRATE ATTACHMENT AND REMARK 1 TITL 2 SEQUENCE HOMOLOGY REMARK 1 REF FEBS LETT. V. 135 301 1981 REMARK 1 REFN ISSN 0014-5793 REMARK 1 REFERENCE 5 REMARK 1 AUTH T.MEGA,E.LUJAN,A.YOSHIDA REMARK 1 TITL STUDIES ON THE OLIGOSACCHARIDE CHAINS OF HUMAN REMARK 1 TITL 2 ALPHA1-PROTEASE INHIBITOR. II. STRUCTURE OF OLIGOSACCHARIDES REMARK 1 REF J.BIOL.CHEM. V. 255 4057 1980 REMARK 1 REFN ISSN 0021-9258 REMARK 2 REMARK 2 RESOLUTION. 3.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : EREF REMARK 3 AUTHORS : JACK,LEVITT REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : NULL REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : NULL REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.193 REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2981 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 138 REMARK 3 SOLVENT ATOMS : 141 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.012 REMARK 3 BOND ANGLES (DEGREES) : 2.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 AN OCCUPANCY AND B VALUE OF 0.0 INDICATES THAT NO REMARK 3 SIGNIFICANT ELECTRON DENSITY WAS FOUND IN THE FINAL FOURIER REMARK 3 MAP. ATOMS WITH THERMAL FACTORS WHICH CALCULATE LESS THAN REMARK 3 6.00 ARE ASSIGNED THIS VALUE. THIS IS THE LOWEST VALUE REMARK 3 ALLOWED BY THE REFINEMENT PROGRAM. REMARK 4 REMARK 4 7API COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000179881. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : NULL REMARK 200 RADIATION SOURCE : NULL REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : NULL REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : NULL REMARK 200 RESOLUTION RANGE HIGH (A) : NULL REMARK 200 RESOLUTION RANGE LOW (A) : NULL REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 74.16 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.76 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 56.75000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 60.25000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 60.25000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 85.12500 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 60.25000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 60.25000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 28.37500 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 60.25000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 60.25000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 85.12500 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 60.25000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 60.25000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 28.37500 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 56.75000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 7490 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 17610 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -16.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 IN THIS ENTRY CHAIN IDENTIFIER *C* IS USED FOR A CYSTEINE REMARK 400 RESIDUE WHICH FORMS A DISULFIDE BOND WITH CYS A 232. SEE REMARK 400 REFERENCE 1 FOR FURTHER DISCUSSION ON THE POSSIBLE ROLE OF REMARK 400 CYS A 232 IN THE PROPOSED STRUCTURE FOR THE ACTIVE REMARK 400 INHIBITOR. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A 12 REMARK 465 THR A 13 REMARK 465 SER A 14 REMARK 465 HIS A 15 REMARK 465 HIS A 16 REMARK 465 ASP A 17 REMARK 465 GLN A 18 REMARK 465 ASP A 19 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 HIS A 20 CB CG ND1 CD2 CE1 NE2 REMARK 480 LYS B 394 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 750 O HOH A 750 7556 1.50 REMARK 500 O HOH A 698 O HOH A 698 7556 1.78 REMARK 500 OG SER A 319 O HOH A 608 4555 2.11 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLY A 123 CA GLY A 123 C 0.100 REMARK 500 TRP A 194 NE1 TRP A 194 CE2 -0.102 REMARK 500 TRP A 238 NE1 TRP A 238 CE2 -0.105 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 21 CA - C - N ANGL. DEV. = -13.3 DEGREES REMARK 500 ARG A 101 NE - CZ - NH2 ANGL. DEV. = -3.3 DEGREES REMARK 500 VAL A 216 CA - CB - CG1 ANGL. DEV. = 9.1 DEGREES REMARK 500 CYS A 232 CB - CA - C ANGL. DEV. = -17.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 70 -137.04 40.35 REMARK 500 ASN A 104 22.83 -74.50 REMARK 500 VAL A 127 95.02 -68.66 REMARK 500 PHE A 147 21.81 -79.52 REMARK 500 ASP A 149 72.66 -113.01 REMARK 500 ASP A 171 45.77 -140.78 REMARK 500 ARG A 196 63.41 -119.77 REMARK 500 ASP A 211 -163.43 -115.43 REMARK 500 ASN A 247 55.29 -92.08 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 ASN A 83 0.08 SIDE CHAIN REMARK 500 TYR A 160 0.09 SIDE CHAIN REMARK 500 ARG A 178 0.18 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 PHE A 23 10.44 REMARK 500 MET A 63 -10.09 REMARK 500 ALA A 70 10.75 REMARK 500 ASN A 104 -10.50 REMARK 500 PRO A 106 -10.49 REMARK 500 ASP A 107 10.16 REMARK 500 LEU A 120 -10.27 REMARK 500 GLN A 156 -10.48 REMARK 500 GLU A 162 -10.42 REMARK 500 THR A 180 15.85 REMARK 500 GLU A 199 12.61 REMARK 500 THR A 203 11.11 REMARK 500 CYS A 232 -10.98 REMARK 500 SER A 237 -16.01 REMARK 500 PRO A 289 -12.44 REMARK 500 LYS A 290 15.08 REMARK 500 THR A 296 10.07 REMARK 500 THR A 309 11.95 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 THE CARBOHYDRATE CHAINS PRESENTED AT THE END OF THIS ENTRY REMARK 600 ARE NOT COMPLETE. SOME OF THE SUGAR RESIDUES COULD NOT BE REMARK 600 LOCATED IN THE ELECTRON DENSITY MAPS. REMARK 615 REMARK 615 ZERO OCCUPANCY ATOM REMARK 615 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 615 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 615 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 615 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 615 M RES C SSEQI REMARK 615 NAG D 2 REMARK 615 NAG C 1 REMARK 615 NAG C 2 REMARK 615 MAN C 3 REMARK 615 MAN C 4 REMARK 615 NAG C 5 REMARK 615 MAN C 6 REMARK 615 NAG D 1 REMARK 615 NAG E 2 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 8API RELATED DB: PDB REMARK 900 RELATED ID: 9API RELATED DB: PDB DBREF 7API A 12 358 UNP P01009 A1AT_HUMAN 36 382 DBREF 7API B 359 394 UNP P01009 A1AT_HUMAN 383 418 SEQRES 1 A 347 ASP THR SER HIS HIS ASP GLN ASP HIS PRO THR PHE ASN SEQRES 2 A 347 LYS ILE THR PRO ASN LEU ALA GLU PHE ALA PHE SER LEU SEQRES 3 A 347 TYR ARG GLN LEU ALA HIS GLN SER ASN SER THR ASN ILE SEQRES 4 A 347 PHE PHE SER PRO VAL SER ILE ALA THR ALA PHE ALA MET SEQRES 5 A 347 LEU SER LEU GLY THR LYS ALA ASP THR HIS ASP GLU ILE SEQRES 6 A 347 LEU GLU GLY LEU ASN PHE ASN LEU THR GLU ILE PRO GLU SEQRES 7 A 347 ALA GLN ILE HIS GLU GLY PHE GLN GLU LEU LEU ARG THR SEQRES 8 A 347 LEU ASN GLN PRO ASP SER GLN LEU GLN LEU THR THR GLY SEQRES 9 A 347 ASN GLY LEU PHE LEU SER GLU GLY LEU LYS LEU VAL ASP SEQRES 10 A 347 LYS PHE LEU GLU ASP VAL LYS LYS LEU TYR HIS SER GLU SEQRES 11 A 347 ALA PHE THR VAL ASN PHE GLY ASP THR GLU GLU ALA LYS SEQRES 12 A 347 LYS GLN ILE ASN ASP TYR VAL GLU LYS GLY THR GLN GLY SEQRES 13 A 347 LYS ILE VAL ASP LEU VAL LYS GLU LEU ASP ARG ASP THR SEQRES 14 A 347 VAL PHE ALA LEU VAL ASN TYR ILE PHE PHE LYS GLY LYS SEQRES 15 A 347 TRP GLU ARG PRO PHE GLU VAL LYS ASP THR GLU GLU GLU SEQRES 16 A 347 ASP PHE HIS VAL ASP GLN VAL THR THR VAL LYS VAL PRO SEQRES 17 A 347 MET MET LYS ARG LEU GLY MET PHE ASN ILE GLN HIS CYS SEQRES 18 A 347 LYS LYS LEU SER SER TRP VAL LEU LEU MET LYS TYR LEU SEQRES 19 A 347 GLY ASN ALA THR ALA ILE PHE PHE LEU PRO ASP GLU GLY SEQRES 20 A 347 LYS LEU GLN HIS LEU GLU ASN GLU LEU THR HIS ASP ILE SEQRES 21 A 347 ILE THR LYS PHE LEU GLU ASN GLU ASP ARG ARG SER ALA SEQRES 22 A 347 SER LEU HIS LEU PRO LYS LEU SER ILE THR GLY THR TYR SEQRES 23 A 347 ASP LEU LYS SER VAL LEU GLY GLN LEU GLY ILE THR LYS SEQRES 24 A 347 VAL PHE SER ASN GLY ALA ASP LEU SER GLY VAL THR GLU SEQRES 25 A 347 GLU ALA PRO LEU LYS LEU SER LYS ALA VAL HIS LYS ALA SEQRES 26 A 347 VAL LEU THR ILE ASP GLU LYS GLY THR GLU ALA ALA GLY SEQRES 27 A 347 ALA MET PHE LEU GLU ALA ILE PRO MET SEQRES 1 B 36 SER ILE PRO PRO GLU VAL LYS PHE ASN LYS PRO PHE VAL SEQRES 2 B 36 PHE LEU MET ILE GLU GLN ASN THR LYS SER PRO LEU PHE SEQRES 3 B 36 MET GLY LYS VAL VAL ASN PRO THR GLN LYS MODRES 7API ASN A 46 ASN GLYCOSYLATION SITE MODRES 7API ASN A 83 ASN GLYCOSYLATION SITE MODRES 7API ASN A 247 ASN GLYCOSYLATION SITE HET NAG C 1 14 HET NAG C 2 14 HET MAN C 3 11 HET MAN C 4 11 HET NAG C 5 14 HET MAN C 6 11 HET NAG D 1 14 HET NAG D 2 14 HET NAG E 1 14 HET NAG E 2 14 HET CYS A 395 7 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETNAM CYS CYSTEINE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN MAN ALPHA-D-MANNOSE; D-MANNOSE; MANNOSE FORMUL 3 NAG 7(C8 H15 N O6) FORMUL 3 MAN 3(C6 H12 O6) FORMUL 6 CYS C3 H7 N O2 S FORMUL 7 HOH *141(H2 O) HELIX 1 A PRO A 21 SER A 45 1 25 HELIX 2 B SER A 53 THR A 68 1 16 HELIX 3 C ALA A 70 ASN A 81 1 12 HELIX 4 D PRO A 88 GLN A 105 1 18 HELIX 5 E VAL A 127 HIS A 139 1 13 HELIX 6 F THR A 150 GLN A 166 1 17 HELIX 7 G GLY A 258 LEU A 267 1 10 HELIX 8 H THR A 268 PHE A 275 1 8 HELIX 9 I LYS A 300 GLY A 307 1 8 SHEET 1 A 6 HIS A 139 ASN A 146 0 SHEET 2 A 6 LEU A 110 GLU A 122 1 SHEET 3 A 6 VAL A 181 LYS A 193 -1 SHEET 4 A 6 LYS A 343 MET A 358 -1 SHEET 5 A 6 LEU A 327 GLU A 342 -1 SHEET 6 A 6 LYS A 290 LYS A 300 -1 SHEET 1 B 6 ASN A 228 LYS A 233 0 SHEET 2 B 6 SER A 236 LEU A 245 -1 SHEET 3 B 6 ALA A 248 PRO A 255 -1 SHEET 4 B 6 PRO B 369 ASN B 378 -1 SHEET 5 B 6 THR B 379 VAL B 389 -1 SHEET 6 B 6 THR A 48 VAL A 55 -1 SHEET 1 C 3 ILE B 360 ASN B 367 0 SHEET 2 C 3 ARG A 282 PRO A 289 1 SHEET 3 C 3 THR A 215 MET A 226 -1 SSBOND 1 CYS A 232 CYS A 395 1555 1555 2.05 LINK ND2 ASN A 46 C1 NAG C 1 1555 1555 1.47 LINK ND2 ASN A 83 C1 NAG D 1 1555 1555 1.49 LINK ND2 ASN A 247 C1 NAG E 1 1555 1555 1.49 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.44 LINK O4 NAG C 2 C1 MAN C 3 1555 1555 1.45 LINK O6 MAN C 3 C1 MAN C 4 1555 1555 1.42 LINK O3 MAN C 3 C1 MAN C 6 1555 1555 1.45 LINK O2 MAN C 4 C1 NAG C 5 1555 1555 1.44 LINK O4 NAG D 1 C1 NAG D 2 1555 1555 1.42 LINK O4 NAG E 1 C1 NAG E 2 1555 1555 1.45 CISPEP 1 ILE B 360 PRO B 361 0 -13.12 CRYST1 120.500 120.500 113.500 90.00 90.00 90.00 P 43 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008299 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008299 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008811 0.00000